Abeezar I Sarela1, Simon P L Dexter, Michael J McMahon. 1. Department of Minimally Invasive Upper GI and Bariatric Surgery, Nuffield Health Leeds Hospital, 2 Leighton Street, Leeds, LS1 3EB, UK. a.sarela@leeds.ac.uk
Abstract
BACKGROUND: This study aimed to evaluate the role of the Obesity Surgery Mortality Risk Score (OS-MRS) to predict the risk of post-operative adverse events, in addition to death, from any laparoscopic bariatric procedure. METHODS: The OS-MRS was applied to consecutive patients at a single hospital during October 2008-September 2009. The composite end point comprised one or more of the following adverse events: mortality, re-intervention, re-admission to hospital, venous thromboemobolism, or blood transfusion. RESULTS: There were 381 patients (men, 19%). The median age was 43 years (range, 19-67 years), with 42% patients aged ≥45 years. The median weight was 126 kg (75-295 kg) and median BMI 46 kg/m(2) (30-84 kg/m(2)); 37% had BMI ≥50 kg/m(2). Twenty-seven percent of patients had hypertension and 3% had a past history of venous thromboembolism. The OS-MRS classes were A (60.1%), B (35.9%), or C (4.0%). Operations comprised adjustable gastric band (37%), Roux-en-Y gastric bypass (54%), sleeve gastrectomy (8%), or biliopancreatic diversion (1%). Of the operations, 1.6% were revisional procedures. An adverse outcome occurred in 19 patients, with distribution in 3.5% of class A patients, 5.8% of class B, and 20.0% of class C (A vs. B, P = 0.451; A vs. C, P = 0.002; B vs. C, P = 0.025). There was one death: OS-MRS class C. On multivariate analysis, OS-MRS (class C vs. A or B; Odds Ratio [OR], 4; P = 0.050) and type of operation (band vs. bypass or sleeve; OR, 9.2; P = 0.033) were independently predictive of the composite end point. CONCLUSION: OS-MRS and type of the bariatric operation are independently predictive of the risk of post-operative adverse events.
BACKGROUND: This study aimed to evaluate the role of the Obesity Surgery Mortality Risk Score (OS-MRS) to predict the risk of post-operative adverse events, in addition to death, from any laparoscopic bariatric procedure. METHODS: The OS-MRS was applied to consecutive patients at a single hospital during October 2008-September 2009. The composite end point comprised one or more of the following adverse events: mortality, re-intervention, re-admission to hospital, venous thromboemobolism, or blood transfusion. RESULTS: There were 381 patients (men, 19%). The median age was 43 years (range, 19-67 years), with 42% patients aged ≥45 years. The median weight was 126 kg (75-295 kg) and median BMI 46 kg/m(2) (30-84 kg/m(2)); 37% had BMI ≥50 kg/m(2). Twenty-seven percent of patients had hypertension and 3% had a past history of venous thromboembolism. The OS-MRS classes were A (60.1%), B (35.9%), or C (4.0%). Operations comprised adjustable gastric band (37%), Roux-en-Y gastric bypass (54%), sleeve gastrectomy (8%), or biliopancreatic diversion (1%). Of the operations, 1.6% were revisional procedures. An adverse outcome occurred in 19 patients, with distribution in 3.5% of class A patients, 5.8% of class B, and 20.0% of class C (A vs. B, P = 0.451; A vs. C, P = 0.002; B vs. C, P = 0.025). There was one death: OS-MRS class C. On multivariate analysis, OS-MRS (class C vs. A or B; Odds Ratio [OR], 4; P = 0.050) and type of operation (band vs. bypass or sleeve; OR, 9.2; P = 0.033) were independently predictive of the composite end point. CONCLUSION: OS-MRS and type of the bariatric operation are independently predictive of the risk of post-operative adverse events.
Authors: Ninh T Nguyen; Mahbod Paya; C Melinda Stevens; Shahrzad Mavandadi; Kambiz Zainabadi; Samuel E Wilson Journal: Ann Surg Date: 2004-10 Impact factor: 12.969
Authors: William B Inabnet; Steven H Belle; Marc Bessler; Anita Courcoulas; Patchen Dellinger; Luis Garcia; James Mitchell; Brant Oelschlager; Robert O'Rourke; John Pender; Alfons Pomp; Walter Pories; Ramesh Ramanathan; Abdus Wahed; Bruce Wolfe Journal: Surg Obes Relat Dis Date: 2009-11-22 Impact factor: 4.734
Authors: Michel M Murr; Taylor Martin; Krista Haines; Tracy Torrella; Robert Dragotti; Ali Kandil; Scott F Gallagher; Scott Harmsen Journal: Ann Surg Date: 2007-05 Impact factor: 12.969
Authors: Eric J DeMaria; Michel Murr; T Karl Byrne; Robin Blackstone; John P Grant; Amanda Budak; Luke Wolfe Journal: Ann Surg Date: 2007-10 Impact factor: 12.969
Authors: Siok S Ching; Abeezar I Sarela; Simon P L Dexter; Jeremy D Hayden; Michael J McMahon Journal: Surg Endosc Date: 2008-07-12 Impact factor: 4.584
Authors: David Benaiges; Antonio Más-Lorenzo; Albert Goday; José M Ramon; Juan J Chillarón; Juan Pedro-Botet; Juana A Flores-Le Roux Journal: World J Gastroenterol Date: 2015-11-07 Impact factor: 5.742
Authors: Noëlle Geubbels; L Maurits de Brauw; Yair I Z Acherman; Arnold W J M van de Laar; Sjoerd C Bruin Journal: Obes Surg Date: 2015-12 Impact factor: 4.129
Authors: Maria Luisa García-García; Juan Gervasio Martín-Lorenzo; Ramón Lirón-Ruiz; José Antonio Torralba-Martínez; José Antonio García-López; José Luis Aguayo-Albasini Journal: Obes Surg Date: 2017-06 Impact factor: 4.129
Authors: U K Coblijn; C A L de Raaff; S M Lagarde; S M M de Castro; B C Vrouenraets; B A van Wagensveld Journal: Obes Surg Date: 2016-09 Impact factor: 4.129